市場調査レポート

商品コード

1490322

医療用外骨格市場：業界動向と世界の予測（～2035年）- 対象部位別、動作モード別、外骨格の形態別、モビリティ別、エンドユーザー別、および主要な地理的地域

Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered, Mode of Operation, Form of Exoskeleton, Mobility, End Users, and Key Geographical Regions

出版日: 2024年03月04日 | 発行: Roots Analysis

| ページ情報: 英文 224 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,799 686,832円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (One-Location Site License)

USD 6,999 1,001,696円

レポートPDFを同一所在地における特定事業ユニットに属する全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Department License)

USD 10,599 1,516,928円

レポートPDFを部署単位で12名様までご利用いただけるライセンスです。同一部署内であれば、地理的に同じ地点に存在する必要はありません。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 17,999 2,576,016円

レポートPDFを同社の国内外拠点における全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.12円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

医療用外骨格の市場規模は、2024年に19億米ドルになるとみられ、予測期間の2024年～2035年に20.8%のCAGRで拡大すると予測されています。

医療用外骨格は、運動障害のある人を支援するために調整されたウェアラブルロボティックデバイスであり、機械、電子、コンピュータ制御システムの融合を利用して、ユーザーの動きを強化し洗練させます。一般的に、怪我や障害によって影響を受ける身体の特定の部位に特化したこれらのデバイスは、車椅子や松葉杖のような従来の補助器具とは一線を画しています。ある種の動力式外骨格技術は、アクチュエーターとセンサーの統合により、ユーザーの筋力とスタミナを増幅することで、能動的な移動支援を提供します。医療用外骨格の可能性は広大で、移動支援を切実に必要としている多くの患者層と共鳴しています。特に神経障害は、公衆衛生上の大きな課題であり、世界中で10億人以上の人々に影響を及ぼしています。

移動障害と闘うかなりの人口にもかかわらず、外骨格市場は、徐々に注目を集めつつあるとはいえ、比較的ニッチな地位を維持しています。これは、外骨格技術に関連するコストの高騰や、患者とヘルスケアプロバイダー双方の認識不足が蔓延していることなど、様々な要因に起因しています。とはいえ、現在進行中の技術的進歩や認知度の向上により、医療用外骨格市場は拡大の態勢を整えており、移動支援を必要とする人々のアクセシビリティや生活の質の向上が期待されています。実際、複数の企業がコントローラーやソフトウェアアプリケーションなどの高度な機能と融合した外骨格技術の開発に先鞭をつけ、ユーザーや臨床医が同様に目標を設定し、補助レベルを微調整し、個別のリハビリ計画に合わせた動作パターンを精査できるようにしています。

当レポートでは、世界の医療用外骨格市場について調査し、市場の概要とともに、対象部位別、動作モード別、外骨格の形態別、モビリティ別、エンドユーザー別、主要地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 5.1 Contrasting Characteristics: Medical and Non-Medical Exoskeleton
Table 5.2 Degrees of Freedom in Each Joint of Lower Exoskeleton
Table 5.3 Contrasting Characteristics: Rigid and Soft Exoskeleton
Table 6.1 Medical Exoskeleton: Information on Status of Development, Type of Body Part Covered and Mode of Operation
Table 6.2 Medical Exoskeleton: Information on Form of Exoskeleton, Device Mobility and User-Machine Interface
Table 6.3 Medical Exoskeleton: Information on Advanced Features and End Users
Table 6.4 Medical Exoskeleton: Information on Patient Age Group, Exoskeleton Setting for Patients and Breakthrough Designation
Table 6.5 Medical Exoskeleton: Information on Technology / Software, Maximum Weight of Exoskeleton, Maximum Weight Carrying Capacity and Dimensions
Table 6.6 Medical Exoskeleton: List of Developers
Table 6.7 Medical Exoskeleton: Information on Additional Services Offered
Table 8.1 List of Medical Exoskeleton Companies Profiled
Table 8.2 CYBERDYNE: Company Snapshot
Table 8.3 CYBERDYNE: Medical Exoskeleton Portfolio
Table 8.4 CYBERDYNE: Recent Developments and Future Outlook
Table 8.5 Ekso Bionics: Company Snapshot
Table 8.6 Ekso Bionics: Medical Exoskeleton Portfolio
Table 8.7 Ekso Bionics: Recent Developments and Future Outlook
Table 8.8 ExoAtlet: Company Snapshot
Table 8.9 ExoAtlet: Medical Exoskeleton Portfolio
Table 8.10 ExoAtlet: Recent Developments and Future Outlook
Table 8.11 Fourier Intelligence: Company Snapshot
Table 8.12 Fourier Intelligence: Medical Exoskeleton Portfolio
Table 8.13 Fourier Intelligence: Recent Developments and Future Outlook
Table 8.14 Gloreha: Company Snapshot
Table 8.15 Gloreha: Medical Exoskeleton Portfolio
Table 8.16 Gloreha: Recent Developments and Future Outlook
Table 8.17 Guangzhou YiKang: Company Snapshot
Table 8.18 Guangzhou YiKang: Medical Exoskeleton Portfolio
Table 8.19 Guangzhou YiKang: Recent Developments and Future Outlook
Table 8.20 Hexar Humancare: Company Snapshot
Table 8.21 Hexar Humancare: Medical Exoskeleton Portfolio
Table 8.22 Hexar Humancare: Recent Developments and Future Outlook
Table 8.23 Hocoma: Company Snapshot
Table 8.24 Hocoma: Medical Exoskeleton Portfolio
Table 8.25 Hocoma: Recent Developments and Future Outlook
Table 8.26 Panasonic: Company Snapshot
Table 8.27 Panasonic: Medical Exoskeleton Portfolio
Table 8.28 Panasonic: Recent Developments and Future Outlook
Table 8.29 Tyromotion: Company Snapshot
Table 8.30 Tyromotion: Medical Exoskeleton Portfolio
Table 8.31 Tyromotion: Recent Developments and Future Outlook
Table 9.1 Bionic Yantra: Company Snapshot and Product Portfolio
Table 9.2 Bionic Yantra: Medical Exoskeleton Portfolio
Table 9.3 MediTouch: Company Snapshot
Table 9.4 MediTouch: Medical Exoskeleton Portfolio
Table 9.5 Milebot Robotics: Company Snapshot
Table 9.6 Milebot Robotics: Medical Exoskeleton Portfolio
Table 9.7 Milebot Robotics: Non- Medical Exoskeleton Portfolio
Table 9.8 Myomo: Company Snapshot
Table 9.9 Myomo: Medical Exoskeleton Portfolio
Table 9.10 Neofect: Company Snapshot
Table 9.11 Neofect: Medical Exoskeleton Portfolio
Table 9.12 NextStep Robotics: Company Snapshot
Table 9.13 NextStep Robotics: Medical Exoskeleton Portfolio
Table 9.14 ReWalk Robotics: Company Snapshot
Table 9.15 ReWalk Robotics: Medical Exoskeleton Portfolio
Table 9.16 REX Bionics: Company Snapshot
Table 9.17 REX Bionics: Medical Exoskeleton Portfolio
Table 9.18 Roam Robotics: Company Snapshot
Table 9.19 Roam Robotics: Medical Exoskeleton Portfolio
Table 9.20 Trexo Robotics: Company Snapshot
Table 9.21 Trexo Robotics: Medical Exoskeleton Portfolio
Table 9.22 U&O Technologies: Company Snapshot
Table 9.23 U&O Technologies: Medical Exoskeleton Portfolio
Table 10.1 Medical Exoskeleton: List of Partnerships and Collaborations
Table 11.1 Patent Analysis: Top CPC Sections
Table 11.2 Patent Analysis: Top CPC Symbols
Table 11.3 Patent Analysis: List of Top CPC Codes
Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
Table 11.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 11.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 11.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 24.1 Medical Exoskeleton: Distribution by Status of Development
Table 24.2 Medical Exoskeleton: Distribution by Body Part Covered
Table 24.3 Medical Exoskeleton: Distribution by Mode of Operation
Table 24.4 Medical Exoskeleton: Distribution by Body Part Covered and Mode of Operation
Table 24.5 Medical Exoskeleton: Distribution by Form of Exoskeleton
Table 24.6 Medical Exoskeleton: Distribution by Mode of Operation and Form of Exoskeleton
Table 24.7 Medical Exoskeleton: Distribution by Body Part Covered and Form of Exoskeleton
Table 24.8 Medical Exoskeleton: Distribution by Device Mobility
Table 24.9 Medical Exoskeleton: Distribution by Mode of Operation and Device Mobility
Table 24.10 Medical Exoskeleton: Distribution by Form of Exoskeleton and Device Mobility
Table 24.11 Medical Exoskeleton: Distribution by Body Part Covered and Device Mobility
Table 24.12 Medical Exoskeleton: Distribution by User-Machine Interface
Table 24.13 Medical Exoskeleton: Distribution by Body Part Covered and User-Machine Interface
Table 24.14 Medical Exoskeleton: Distribution by Mode of Operation and User-Machine Interface
Table 24.15 Medical Exoskeleton: Distribution by Availability of Advanced Features
Table 24.16 Medical Exoskeleton: Distribution by End User
Table 24.17 Medical Exoskeleton: Distribution by Patient Age Group
Table 24.18 Medical Exoskeleton: Distribution by Exoskeleton Setting for Patients
Table 24.19 Medical Exoskeleton: Distribution by Breakthrough Designation
Table 24.20 Medical Exoskeleton Developers: Distribution by Year of Establishment
Table 24.21 Medical Exoskeleton Developers: Distribution by Company Size
Table 24.22 Medical Exoskeleton Developers: Distribution by Company Size and Employee Count
Table 24.23 Medical Exoskeleton Developers: Distribution by Location of Headquarters (Region)
Table 24.24 Medical Exoskeleton Developers: Distribution by Location of Headquarters (Country)
Table 24.25 Medical Exoskeleton Developers: Distribution by Company Size and Location of Headquarters
Table 24.26 Medical Exoskeleton Developers: Distribution by Company Ownership
Table 24.27 Medical Exoskeleton Developers: Distribution by Location of Headquarters and Company Ownership
Table 24.28 Medical Exoskeleton Developers: Distribution by Additional Services Offered
Table 24.29 Most Active Players: Distribution by Number of Medical Exoskeleton
Table 24.30 CYBERDYNE: Annual Revenues, FY2019 - FY2023 (JPY Billion)
Table 24.31 CYBERDYNE: Distribution of Revenues by Business Segment, FY 2021- FY 2022
Table 24.32 Ekso Bionics: Annual Revenues, 2018 - Q1 2023 (USD Billion)
Table 24.33 Ekso Bionics: Distribution of Revenues by Business Segment, FY 2023
Table 24.34 Panasonic: Annual Revenues, FY 2018- FY 2023 (JPY Billion)
Table 24.35 Partnerships and Collaborations: Distribution by Year of Partnership
Table 24.36 Partnerships and Collaborations: Distribution by Type of Partnership
Table 24.37 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 24.38 Partnerships and Collaborations: Distribution by Type of Partner
Table 24.39 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Table 24.40 Partnerships and Collaborations: Distribution by Purpose of Partnership
Table 24.41 Partnerships and Collaborations: Local and International Agreements
Table 24.42 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Table 24.43 Most Active Players: Distribution by Number of Partnerships
Table 24.44 Patent Analysis: Distribution by Type of Patent
Table 24.45 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Pre-2016- 2022
Table 24.46 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, 2016-2022
Table 24.47 Patent Analysis: Distribution by Type of Patent and Patent Publication Year, 2016-2023
Table 24.48 Patent Analysis: Distribution by Publication Time
Table 24.49 Patent Analysis: Distribution by Patent Jurisdiction (Region)
Table 24.50 Patent Analysis: Distribution by Patent Jurisdiction (Country)
Table 24.51 Patent Analysis: Distribution by CPC Symbols
Table 24.52 Patent Analysis: Distribution by Type of Applicant
Table 24.53 Leading Industry Players: Distribution by Number of Patents
Table 24.54 Leading Non-Industry Players: Distribution by Number of Patents
Table 24.55 Leading Individual Assignees: Distribution by Number of Patents
Table 24.56 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Table 24.57 Leading Non-Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Table 24.58 Patent Analysis: Distribution by Patent Age
Table 24.59 Patent Analysis: Patent Valuation
Table 24.60 Medical Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 24.61 Medical Exoskeleton Market, Forecasted Estimates (2023-2035), Base Scenario (USD Million)
Table 24.62 Medical Exoskeleton Market, Forecasted Estimates (2023-2035) Conservative Scenario (USD Million)
Table 24.63 Medical Exoskeleton Market, Forecasted Estimates (2023-2035), Optimistic Scenario (USD Million)
Table 24.64 Medical Exoskeleton Market: Distribution by Body Part Covered, 2018, 2023 and 2035 (USD Million)
Table 24.65 Medical Upper Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.66 Medical Lower Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.67 Medical Full Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.68 Medical Exoskeleton Market: Distribution by Mode of Operation, 2018, 2023 and 2035 (USD Million)
Table 24.69 Medical Powered Exoskeleton Market: Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
Table 24.70 Medical Passive Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.71 Medical Hybrid Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.72 Medical Exoskeleton Market: Distribution by Form 2018, 2023 and 2035 (USD Million)
Table 24.73 Medical Rigid Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.74 Medical Soft Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.75 Medical Exoskeleton Market: Distribution by Device Mobility, 2018, 2023 and 2035 (USD Million)
Table 24.76 Medical Fixed / Supported Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.77 Medical Mobile / Overground Walking Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.78 Medical Exoskeleton Market: Distribution by End Users, 2018, 2023 and 2035 (USD Million)
Table 24.79 Medical Exoskeleton Market by Patients: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.80 Medical Exoskeleton Market by Healthcare Professionals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 24.81 Medical Exoskeleton Market: Distribution by Geography, 2018, 2023 and 2035 (USD Million)
Table 24.82 Medical Exoskeleton Market in North America: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
Table 24.83 Medical Exoskeleton Market in Europe: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
Table 24.84 Medical Exoskeleton Market in Asia-Pacific: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
Table 24.85 Medical Exoskeleton Market in Rest of the World: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)

List of Figures

Figure 2.1 Research Methodology: Research Assumptions
Figure 2.2 Research Methodology: Project Methodology
Figure 2.3 Research Methodology: Forecast Methodology
Figure 2.4 Research Methodology: Robust Quality Control
Figure 2.5 Research Methodology: Key Market Segmentations
Figure 4.1 Executive Summary: Medical Exoskeleton Market Landscape
Figure 4.2 Executive Summary: Partnerships and Collaborations
Figure 4.3 Executive Summary: Patent Analysis
Figure 4.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 5.1 Types of Mobility Assistive Devices
Figure 5.2 Key Historical Events related to Exoskeleton
Figure 5.3 Classification of Exoskeleton
Figure 5.4 Applications of Exoskeleton
Figure 5.5 Movements Supported by Lower Body, Upper Body and Full Body Exoskeleton
Figure 5.6 Components of a Powered / Robotic Exoskeleton
Figure 5.7 Features of Exoskeleton
Figure 5.8 Limitations of Exoskeleton
Figure 6.1 Medical Exoskeleton: Distribution by Status of Development
Figure 6.2 Medical Exoskeleton: Distribution by Type of Body Part Covered
Figure 6.3 Medical Exoskeleton: Distribution by Mode of Operation
Figure 6.4 Medical Exoskeleton: Distribution Type of Body Part Covered and Mode of Operation
Figure 6.5 Medical Exoskeleton: Distribution by Form of Exoskeleton
Figure 6.6 Medical Exoskeleton: Distribution by Mode of Operation and Form of Exoskeleton
Figure 6.7 Medical Exoskeleton: Distribution Type of Body Part Covered and Form of Exoskeleton
Figure 6.8 Medical Exoskeleton: Distribution by Device Mobility
Figure 6.9 Medical Exoskeleton: Distribution by Mode of Operation and Device Mobility
Figure 6.10 Medical Exoskeleton: Distribution by Form of Exoskeleton and Device Mobility
Figure 6.11 Medical Exoskeleton: Distribution by Type of Body Part Covered and Device Mobility
Figure 6.12 Medical Exoskeleton: Distribution by User-Machine Interface
Figure 6.13 Medical Exoskeleton: Distribution by Type of Body Part Covered and User-Machine Interface
Figure 6.14 Medical Exoskeleton: Distribution by Mode of Operation and User-Machine Interface
Figure 6.15 Medical Exoskeleton: Distribution by Availability of Advanced Features
Figure 6.16 Medical Exoskeleton: Distribution by End User
Figure 6.17 Medical Exoskeleton: Distribution by Patient Age Group
Figure 6.18 Medical Exoskeleton: Distribution by Exoskeleton Setting for Patients
Figure 6.19 Medical Exoskeleton: Distribution by Breakthrough Designation
Figure 6.20 Medical Exoskeleton Companies: Distribution by Year of Establishment
Figure 6.21 Medical Exoskeleton Companies: Distribution by Company Size
Figure 6.22 Medical Exoskeleton Companies: Distribution by Company Size and Employee Count
Figure 6.23 Medical Exoskeleton Companies: Distribution by Location of Headquarters (Region)
Figure 6.24 Medical Exoskeleton Companies: Distribution by Location of Headquarters (Country)
Figure 6.25 Medical Exoskeleton Companies: Distribution by Company Size and Location of Headquarters
Figure 6.26 Medical Exoskeleton Companies: Distribution by Company Ownership
Figure 6.27 Medical Exoskeleton Companies: Distribution by Location of Headquarters and Company Ownership
Figure 6.28 Medical Exoskeleton Companies: Distribution by Additional Services Offered
Figure 6.29 Most Active Players: Distribution by Number of Medical Exoskeleton Location of Headquarters (Country)
Figure 7.1 Product Competitiveness Analysis: Upper Body, Powered Exoskeleton
Figure 7.2 Product Competitiveness Analysis: Upper Body, Passive Exoskeleton
Figure 7.3 Product Competitiveness Analysis: Upper Body, Hybrid Exoskeleton
Figure 7.4 Product Competitiveness Analysis: Lower Body, Powered Exoskeleton
Figure 7.5 Product Competitiveness Analysis: Lower Body, Passive Exoskeleton
Figure 7.6 Product Competitiveness Analysis: Lower Body, Hybrid Exoskeleton
Figure 7.7 Product Competitiveness Analysis: Full Body Medical Exoskeleton
Figure 8.1 CYBERDYNE: Annual Revenues, FY 2019 - FY 2023 (JPY Billion)
Figure 8.2 CYBERDYNE: Distribution of Revenues by Business Segment, FY 2021- FY 2022
Figure 8.3 Ekso Bionics: Annual Revenues, 2018 - Q1 2023 (USD Billion)
Figure 8.4 Ekso Bionics: Distribution of Revenues by Business Segment, FY 2023
Figure 8.5 Panasonic: Annual Revenues, FY 2018- FY 2023 (JPY Billion)
Figure 10.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 10.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 10.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 10.6 Partnerships and Collaborations: Distribution by Purpose of Partnership
Figure 10.7 Partnerships and Collaborations: Local and International Agreements
Figure 10.8 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 10.9 Most Active Players: Distribution by Number of Partnerships
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Pre-2016-2022
Figure 11.3 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, 2016-2022
Figure 11.4 Patent Analysis: Distribution by Type of Patent and Patent Publication Year, 2016-2023
Figure 11.5 Patent Analysis: Distribution by Publication Time
Figure 11.6 Patent Analysis: Distribution by Patent Jurisdiction (Region)
Figure 11.7 Patent Analysis: Distribution by Patent Jurisdiction (Country)
Figure 11.8 Patent Analysis: Distribution by CPC Symbols
Figure 11.9 Patent Analysis: Distribution by Type of Applicant
Figure 11.10 Leading Industry Players: Distribution by Number of Patents
Figure 11.11 Leading Non-Industry Players: Distribution by Number of Patents
Figure 11.12 Leading Individual Assignees: Distribution by Number of Patents
Figure 11.13 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Figure 11.14 Leading Non-Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Figure 11.15 Patent Analysis: Distribution by Patent Age
Figure 11.16 Patent Analysis: Patent Valuation
Figure 12.1 Differences Between Red Ocean Strategy and Blue Ocean Strategy
Figure 12.2 Blue Ocean Strategy: Strategy Canvas
Figure 12.3 Blue Ocean Strategy: Pioneer- Migrator-Settler (PMS) Map
Figure 12.4 Blue Ocean Strategy: Buyer Utility Map
Figure 13.1 Market Drivers
Figure 13.2 Market Restrains
Figure 13.3 Market Opportunities
Figure 13.4 Market Challenges
Figure 14.1 Medical Exoskeleton Market, Historical Trends (2018-2022) and Future Estimates (2023-2035) (USD Million)
Figure 14.2 Medical Exoskeleton Market, Future Estimates (2023-2035), Base Scenario (USD Million)
Figure 14.3 Medical Exoskeleton Market, Future Estimates (2023-2035), Conservative Scenario (USD Million)
Figure 14.4 Medical Exoskeleton Market, Future Estimates (2023-2035), Optimistic Scenario (USD Million)
Figure 15.1 Medical Exoskeleton Market: Distribution by Body Part Covered, 2018, 2023 and 2035 (USD Million)
Figure 15.2 Medical Upper Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 15.3 Medical Lower Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023- 2035)
Figure 15.4 Medical Full Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.1 Medical Exoskeleton Market: Distribution by Mode of Operation, 2018, 2023 and 2035 (USD Million)
Figure 16.2 Medical Powered Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.3 Medical Passive Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 16.4 Medical Hybrid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.1 Medical Exoskeleton Market: Distribution by Form, 2018, 2023 and 2035 (USD Million)
Figure 17.2 Medical Rigid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 17.3 Medical Soft Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 18.1 Medical Exoskeleton Market: Distribution by Device Mobility, 2018, 2023 and 2035 (USD Million)
Figure 18.2 Medical Fixed / Supported Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 18.3 Medical Mobile / Overground Walking Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 19.1 Medical Exoskeleton Market: Distribution by End Users, 2018, 2023 and 2035 (USD Million)
Figure 19.2 Medical Exoskeleton Market by Patients: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 19.3 Medical Exoskeleton Market by Healthcare Professionals: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.1 Medical Exoskeleton Market: Distribution by Geography, 2018, 2023 and 2035 (USD Million)
Figure 20.2 Medical Exoskeleton Market in North America: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.3 Medical Exoskeleton Market in Europe: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.4 Medical Exoskeleton Market in Asia- Pacific: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 20.5 Medical Exoskeleton Market in Rest of the World: Historical Trends (2018-2022) and Future Estimates (2023-2035)
Figure 21.4 Concluding Remarks: Overall Medical Exoskeleton Market Landscape
Figure 21.3 Concluding Remarks: Partnerships and Collaborations
Figure 21.4 Concluding Remarks: Patent Analysis
Figure 21.5 Concluding Remarks: Market Forecast and Opportunity Analysis

Product Code: RAU1028

Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered (Upper Body, Lower Body and Full Body), Mode of Operation (Powered, Passive and Hybrid), Form of Exoskeleton (Rigid and Soft), Mobility (Fixed / Supported and Mobile), End Users (Patients and Healthcare Providers), and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World)

The Medical Exoskeleton Market is valued at USD 1.90 billion in 2024 growing at a CAGR of 20.8% during the forecast period 2024-2035.

Medical exoskeletons, wearable robotic devices tailored to aid individuals with mobility impairments, harness a blend of mechanical, electronic, and computer-controlled systems to bolster and refine the user's movement. Typically, homing in on specific body parts affected by injury or disability, these devices diverge from conventional assistive tools like wheelchairs and crutches. Certain iterations of powered exoskeleton technology furnish active mobility assistance by amplifying the user's strength and stamina through the integration of actuators and sensors. The potential of medical exoskeletons is vast, resonating with a considerable patient demographic in dire need of mobility support. Neurological disorders, in particular, pose a formidable public health challenge, impacting over one billion individuals worldwide. Traumatic brain injury (TBI), as highlighted by the Lancet Neurology Commission, stands as a pervasive global concern afflicting 55 million people, while current estimates suggest a populace of 20.6 million grappling with spinal cord injury.

Despite the substantial population contending with mobility impairments, the exoskeleton market maintains a relatively niche status, albeit gradually garnering attention. This can be attributed to various factors, including the elevated costs associated with exoskeleton technology and a prevalent lack of awareness among both patients and healthcare providers. Nonetheless, with ongoing technological strides and heightened awareness, the medical exoskeleton market stands poised for expansion, offering the promise of enhanced accessibility and quality of life for those in need of mobility assistance. Indeed, several companies are spearheading the development of exoskeleton technology fused with advanced features such as controllers and software applications, empowering users and clinicians alike to establish goals, fine-tune assistance levels, and scrutinize movement patterns tailored to personalized rehabilitation plans.

Key Market Segments

Body Part Covered

Upper Extremity
Lower Extremity
Full Body

Mode of Operation

Powered
Passive
Hybrid

Form

Rigid
Soft

Mobility

Fixed / Supported
Mobile

End Users

Patients
Healthcare Providers

Geography

North America
Europe
Asia-Pacific
Rest of the World

Research Coverage:

An insightful overview of exoskeleton industry, highlighting details on origin of exoskeletons. This chapter provides information on classification of exoskeleton, along with applications, features and limitations associated with exoskeleton. Further, it concludes with a discussion on future perspectives in this domain.
This overview provides insight into the current market landscape of medical exoskeletons, considering various parameters such as development status (commercialized and under development), body part coverage (upper extremity, lower extremity, and full body), mode of operation (powered, passive, and hybrid), exoskeleton form (rigid and soft exosuit), mobility (stationary and mobile), user-machine interface (including app-based, handheld controller, on-device buttons/control panels, and brain control), and advanced features (such as data capture, gamification, and customized assistance). Additionally, it addresses end users (patients, medical professionals, and researchers), patient age groups (pediatric to adolescent, adolescent to elderly), and exoskeleton settings (home/community and rehabilitation centers). It also touches on breakthrough device designations, exoskeleton technology/software, maximum weight, weight carrying capacity, and dimensions. Furthermore, it lists companies involved in medical exoskeleton development/commercialization, providing details on establishment year, company size, headquarters location, ownership, and additional services. Lastly, it highlights the most active companies in terms of medical exoskeleton offerings.
A comprehensive analysis of product competitiveness within the medical exoskeleton market, focusing on supplier strength (including years of experience, company size, and exoskeleton portfolio), product competitiveness (encompassing device mobility, exoskeleton form, operation mode, advanced features, user-machine interface, additional services, breakthrough designation, and development status), and target end users.
Comprehensive profiles of prominent medical exoskeleton companies selected based on the quantity and application scope of wearable exoskeletons in their product lineup. Each profile provides a succinct overview of the company, including establishment year, employee count, headquarters location, and leadership team details, along with insights into financial performance where applicable. Additionally, the profiles encompass information on the company's product range, recent advancements, and an informed perspective on future prospects.
Tabulated summaries of leading medical exoskeleton companies selected based on the quantity and application range of wearable exoskeletons in their product offerings. Each tabulated profile provides an overview of the company, detailing establishment year, employee count, headquarters location, and key leadership team members. Additionally, the profiles include information on the company's product portfolio.
A comprehensive analysis of the medical exoskeleton market's recent partnerships and collaborations established since 2017. This analysis considers various parameters, including the year of partnership, partnership type (such as mergers and acquisitions, product development and commercialization agreements, licensing agreements, service agreements, product development and manufacturing agreements, joint ventures, manufacturing and supply agreements, and product distribution agreements), partner type (industry and non-industry), business globalization trends, and the most active players. Additionally, it provides insights into the regional distribution of the companies engaged in these agreements.
A thorough examination of patents filed or granted for exoskeletons since 2016, encompassing diverse relevant factors such as patent type, application and publication years, geographical origins, applicant types, publication timelines, top CPC symbols, and key players in terms of the quantity of patents filed or granted. Additionally, it includes an in-depth patent benchmarking analysis.
An exhaustive examination of the present and prospective market through the lens of the Blue Ocean Strategy, providing a strategic roadmap for nascent medical exoskeleton enterprises to tap into uncontested market spaces. This guide encompasses thirteen strategic tools aimed at facilitating a transition towards a Blue Ocean strategy, enabling companies to secure a competitive advantage in the market.
A comprehensive examination of the factors influencing the expansion of the medical exoskeleton market. This analysis includes the identification and evaluation of significant drivers, potential limitations, emerging prospects, and current obstacles.

Key Benefits of Buying this Report

The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
The report provides stakeholders with a pulse on the Medical Exoskeleton Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Leading Market Companies

Bionic Yantra

CYBERDYNE

Ekso Bionics
ExoAtlet
Fourier Intelligence
Gloreha
Guangzhou Yikang Medical Equipment
Hexar Humancare
Hocoma
MediTouch
Milebot Robotics
Myomo
Neofect
NextStep Robotics
Panasonic
ReWalk Robotics
Rex Bionics
Roam Robotics
Trexo Robotics
Tyromotion
U&O Technologies

Table Of Contents

1. PREFACE

1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
- 2.7.1. Demographics
- 2.7.2. Economic Factors
- 2.7.3. Government Regulations
- 2.7.4. Supply Chain
- 2.7.5. COVID Impact / Related Factors
- 2.7.6. Market Access
- 2.7.7. Healthcare Policies
- 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

3.1. Chapter Overview
3.2. Market Dynamics
- 3.2.1. Time Period
  - 3.2.1.1. Historical Trends
  - 3.2.1.2. Current and Forecasted Estimates
- 3.2.2. Currency Coverage
  - 3.2.2.1. Overview of Major Currencies Affecting the Market
  - 3.2.2.2. Impact of Currency Fluctuations on the Industry
- 3.2.3. Foreign Exchange Impact
  - 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
  - 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
- 3.2.4. Recession
  - 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
  - 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
- 3.2.5. Inflation
  - 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
  - 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

5.1. Chapter Overview
5.2. Overview of Exoskeleton
5.3. History of Exoskeleton
5.4. Classification of Exoskeleton
- 5.4.1. Based on Body Part Supported
- 5.4.2. Based on Form of Exoskeleton
- 5.4.3. Based on Mode of Operation
- 5.4.4 Based on Mobility
5.5. Applications of Exoskeleton
5.6. Features of Exoskeleton
5.7. Limitations of Exoskeleton
5.8. Future Perspectives

6. MEDICAL EXOSKELETON: MARKET LANDSCAPE

6.1. Chapter Overview
6.2. Medical Exoskeleton: Overall Market Landscape
- 6.2.1. Analysis by Status of Development
- 6.2.2. Analysis by Type of Body Part Covered
- 6.2.3. Analysis by Mode of Operation
- 6.2.4. Analysis by Type of Body Part Covered and Mode of Operation
- 6.2.5. Analysis by Form of Exoskeleton
- 6.2.6. Analysis by Mode of Operation and Form of Exoskeleton
- 6.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
- 6.2.8. Analysis by Device Mobility
- 6.2.9. Analysis by Mode of Operation and Device Mobility
- 6.2.10. Analysis by Form of Exoskeleton and Device Mobility
- 6.2.11. Analysis by Type of Body Part Covered and Device Mobility
- 6.2.12. Analysis by User-Machine Interface
- 6.2.13. Analysis by Type of Body Part Covered and User-Machine Interface
- 6.2.14. Analysis by Mode of Operation and User-Machine Interface
- 6.2.15. Analysis by Availability of Advanced Features
- 6.2.16. Analysis by End User
- 6.2.17. Analysis by Patient Age Group
- 6.2.18. Analysis by Exoskeleton Setting for Patients
- 6.2.19. Analysis by Breakthrough Designation
6.3. Medical Exoskeleton: Developer: Landscape
- 6.3.1. Analysis by Year of Establishment
- 6.3.2. Analysis by Company Size
- 6.3.3. Analysis by Location of Headquarters
- 6.3.4. Analysis by Company Size and Location of Headquarters
- 6.3.5. Analysis by Company Ownership
- 6.3.6. Analysis by Location of Headquarters and Company Ownership
- 6.3.7. Analysis by Additional Services Offered
- 6.3.8. Most Active Players: Analysis by Number of Medical Exoskeleton

7. MEDICAL EXOSKELETON: PRODUCT COMPETITIVENESS ANALYSIS

7.1 Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Medical Exoskeleton: Product Competitiveness Analysis
- 7.4.1. Product Competitiveness Analysis: Upper Body Medical Exoskeleton
  - 7.4.1.1. Product Competitiveness Analysis: Upper Body, Powered Exoskeleton
  - 7.4.1.2. Product Competitiveness Analysis: Upper Body, Passive Exoskeleton
  - 7.4.1.3. Product Competitiveness Analysis: Upper Body, Hybrid Exoskeleton
- 7.4.2. Product Competitiveness Analysis: Lower Body Exoskeleton
  - 7.4.2.1. Product Competitiveness Analysis: Lower Body, Powered Exoskeleton
  - 7.4.2.2. Product Competitiveness Analysis: Lower Body, Passive Exoskeleton
  - 7.4.2.3. Product Competitiveness Analysis: Lower Body, Hybrid Exoskeleton
- 7.4.3. Product Competitiveness Analysis: Full Body Medical Exoskeleton

8. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES

8.1. Chapter Overview
8.2. CYBERDYNE
- 8.2.1. Company Overview
- 8.2.2. Financial Information
- 8.2.3. Product Portfolio
- 8.2.4 Recent Developments and Future Outlook
8.3. Ekso Bionics
- 8.3.1. Company Overview
- 8.3.2. Financial Information
- 8.3.3. Product Portfolio
- 8.3.4 Recent Developments and Future Outlook
8.4. ExoAtlet
- 8.4.1. Company Overview
- 8.4.2. Product Portfolio
- 8.4.3. Recent Developments and Future Outlook
8.5. Fourier Intelligence
- 8.5.1. Company Overview
- 8.5.2. Product Portfolio
- 8.5.3. Recent Developments and Future Outlook
8.6. Gloreha
- 8.6.1. Company Overview
- 8.6.2. Product Portfolio
- 8.6.3. Recent Developments and Future Outlook
8.7. Guangzhou Yikang
- 8.7.1. Company Overview
- 8.7.2. Product Portfolio
- 8.7.3. Recent Developments and Future Outlook
8.8. Hexar Humancare
- 8.8.1. Company Overview
- 8.8.2. Product Portfolio
- 8.8.3. Recent Developments and Future Outlook
8.9. Hocoma
- 8.9.1. Company Overview
- 8.9.2. Product Portfolio
- 8.9.3. Recent Developments and Future Outlook
8.10. Panasonic
- 8.10.1. Company Overview
- 8.10.2. Financial Information
- 8.10.3. Product Portfolio
- 8.10.4. Recent Developments and Future Outlook
8.11. Tyromotion
- 8.11.1. Company Overview
- 8.11.2. Product Portfolio
- 8.11.3. Recent Developments and Future Outlook

9. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES

9.1. Chapter Overview
9.2. Bionic Yantra
9.3. MediTouch
9.4. Milebot Robotics
9.5. Myomo
9.6. Neofect
9.7. NextStep Robotics
9.8. ReWalk Robotics
9.9. Rex Bionics
9.10. Roam Robotics
9.11. Trexo Robotics
9.12. U&O Technologies

10. MEDICAL EXOSKELETON: PARTNERSHIPS AND COLLABORATIONS

10.1. Chapter Overview
10.2. Partnership Models
10.3. Medical Exoskeleton: List of Partnerships and Collaborations
- 10.3.1. Analysis by Year of Partnership
- 10.3.2. Analysis by Type of Partnership
- 10.3.3. Analysis by Year and Type of Partnership
- 10.3.4. Analysis by Type of Partner
- 10.3.5. Analysis by Year of Partnership and Type of Partner
- 10.3.6. Analysis by Purpose of Partnership
- 10.3.7. Analysis by Geography
  - 10.3.7.1. Local and International Agreements
  - 10.3.7.2. Intracontinental and Intercontinental Agreements
  - 10.3.7.3. Most Active Players: Distribution by Number of Partnerships

11. PATENT ANALYSIS

11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Exoskeleton: Patent Analysis
- 11.3.1. Analysis by Patent Application Year
- 11.3.2. Analysis by Patent Publication Year
- 11.3.3. Analysis by Type of Patent and Patent Publication Year
- 11.3.4. Analysis by Publication Time
- 11.3.5. Analysis by Patent Jurisdiction
- 11.3.6. Analysis by CPC symbols
- 11.3.7. Analysis by Type of Applicant
- 11.3.8. Leading Players: Analysis by Number of Patents
- 11.3.9. Leading Patent Assignees: Analysis by Number of Patents
11.4. Exoskeleton: Patent Benchmarking
- 11.4.1. Analysis by Patent Characteristics
- 11.4.2. Exoskeleton: Patent Valuation
11.5. Leading Players by Number of Citations

12. BLUE OCEAN STRATEGY

12.1. Overview of Blue Ocean Strategy
- 12.1.1. Red Oceans
- 12.1.2. Blue Oceans
- 12.1.3. Comparison of Red Ocean Strategy and Blue Ocean Strategy
- 12.1.4. Medical Exoskeleton: Blue Ocean Strategy and Shift Tools
  - 12.1.4.1. Strategy Canvas
  - 12.1.4.2. Pioneer-Migrator-Settler (PMS) Map
  - 12.1.4.3. Buyer Utility Map

13. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

13.1. Chapter Overview
13.2. Market Drivers
13.3. Market Restraints
13.4. Market Opportunities
13.5. Market Challenges
13.6. Conclusion

14. MEDICAL EXOSKELETON MARKET

14.1. Chapter Overview
14.2. Forecast Methodology and Key Assumptions
14.3. Medical Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 14.3.1. Scenario Analysis
14.4. Key Market Segmentations
14.5. Dynamic Dashboard

15. EXOSKELETON MARKET, BY BODY PART COVERED

15.1. Chapter Overview
15.2. Forecast Methodology and Key Assumptions
15.3. Medical Upper Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.4. Medical Lower Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.5. Medical Full Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.6. Data Triangulation and Validation

16. EXOSKELETON MARKET, BY MODE OF OPERATION

16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. Medical Powered Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Medical Passive Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.5. Medical Hybrid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.6. Data Triangulation and Validation

17. EXOSKELETON MARKET, BY THEIR FORM

17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions
17.3. Medical Rigid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4. Medical Soft Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.5. Data Triangulation and Validation

18. EXOSKELETON MARKET, BY THEIR MOBILITY

18.1. Chapter Overview
18.2. Forecast Methodology and Key Assumptions
18.3. Medical Fixed/ Supported Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.4. Medical Mobile / Overground Walking Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.5. Data Triangulation and Validation

19. EXOSKELETON MARKET, BY END USERS

19.1. Chapter Overview
19.2. Forecast Methodology and Key Assumptions
19.3. Medical Exoskeleton by Patients: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.4. Medical Exoskeleton by Healthcare Providers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.5. Data Triangulation and Validation

20. EXOSKELETON MARKET, BY GEOGRAPHY

20.1. Chapter Overview
20.2. Forecast Methodology and Key Assumptions
20.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.5. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.6. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.7. Data Triangulation and Validation

21. CONCLUSION

22. EXECUTIVE INSIGHTS

22.1. Chapter Overview
22.2. Spain-based Small Company
- 22.2.1. Company Snapshot
- 22.2.2. Interview Transcript: Co-Founder and Chief Executive Officer
22.3. Japan-based Small Company
- 22.3.1. Company Snapshot
- 22.3.2. Interview Transcript: Director of Business Planning and Development
22.4. US-based Small Company
- 22.4.1. Company Snapshot
- 22.4.2. Interview Transcript: Vice President of Sales and Marketing
22.5. Canada-based Small Company
- 22.5.1. Company Snapshot
- 22.5.2. Interview Transcript: Marketing and Design Manager
22.6. India-based Small Company
- 22.6.1. Company Snapshot
- 22.6.2. Interview Transcript: Founder and Director

医療用外骨格市場：業界動向と世界の予測（～2035年）- 対象部位別、動作モード別、外骨格の形態別、モビリティ別、エンドユーザー別、および主要な地理的地域

Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered, Mode of Operation, Form of Exoskeleton, Mobility, End Users, and Key Geographical Regions

目次

第1章 序文

第2章 調査手法

第3章 経済およびその他のプロジェクト特有の考慮事項

第4章 エグゼクティブサマリー

第5章 イントロダクション

第6章 医療用外骨格：市場情勢

第7章 医療用外骨格：製品競合分析

第8章 外骨格開発企業：詳細な企業プロファイル

第9章 外骨格開発企業：企業プロファイル一覧

第10章 医療用外骨格：パートナーシップとコラボレーション

第11章 特許分析

第12章 ブルーオーシャン戦略

第13章 市場への影響分析：促進要因、抑制要因、機会、課題

第14章 医療用外骨格市場

第15章 外骨格市場、対象部位別

第16章 外骨格市場、動作モード別

第17章 外骨格市場、形態別

第18章 外骨格市場、モビリティ別

第19章 外骨格市場、エンドユーザー別

第20章 外骨格市場、地域別

第21章 結論

第22章 エグゼクティブ洞察

第23章 付録1 ブルーオーシャン戦略とシフトツール

第24章 付録2 表データ

第25章 付録3 企業および組織の一覧

List of Tables

List of Figures

CYBERDYNE

TABLE OF CONTENTS

1. PREFACE

2. RESEARCH METHODOLOGY

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

4. EXECUTIVE SUMMARY

5. INTRODUCTION

6. MEDICAL EXOSKELETON: MARKET LANDSCAPE

7. MEDICAL EXOSKELETON: PRODUCT COMPETITIVENESS ANALYSIS

8. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES

9. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES

10. MEDICAL EXOSKELETON: PARTNERSHIPS AND COLLABORATIONS

11. PATENT ANALYSIS

12. BLUE OCEAN STRATEGY

13. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

14. MEDICAL EXOSKELETON MARKET

15. EXOSKELETON MARKET, BY BODY PART COVERED

16. EXOSKELETON MARKET, BY MODE OF OPERATION

17. EXOSKELETON MARKET, BY THEIR FORM

18. EXOSKELETON MARKET, BY THEIR MOBILITY

19. EXOSKELETON MARKET, BY END USERS

20. EXOSKELETON MARKET, BY GEOGRAPHY

21. CONCLUSION

22. EXECUTIVE INSIGHTS

23. APPENDIX 1: BLUE OCEAN STRATEGY AND SHIFT TOOLS

24. APPENDIX 2: TABULATED DATA

25. APPENDIX 3: LIST OF COMPANIES AND ORGANIZATION

第1章序文

第2章調査手法

第3章経済およびその他のプロジェクト特有の考慮事項

第4章エグゼクティブサマリー

第5章イントロダクション

第6章医療用外骨格：市場情勢

第7章医療用外骨格：製品競合分析

第8章外骨格開発企業：詳細な企業プロファイル

第9章外骨格開発企業：企業プロファイル一覧

第10章医療用外骨格：パートナーシップとコラボレーション

第11章特許分析

第12章ブルーオーシャン戦略

第13章市場への影響分析：促進要因、抑制要因、機会、課題

第14章医療用外骨格市場

第15章外骨格市場、対象部位別

第16章外骨格市場、動作モード別

第17章外骨格市場、形態別

第18章外骨格市場、モビリティ別

第19章外骨格市場、エンドユーザー別

第20章外骨格市場、地域別

第21章結論

第22章エグゼクティブ洞察

第23章付録1 ブルーオーシャン戦略とシフトツール

第24章付録2 表データ

第25章付録3 企業および組織の一覧